| Literature DB >> 22523712 |
Abstract
Objectives. Outcome assessment of the Marshall coughing test (MT) during cervix reposition maneuver (CRM) in women with urinary stress incontinence (USI) with/without genital prolapse (GP). Study Design. 268 patients, divided into USIg (n = 132) with isolated USI and USIGPg (n = 136) with USI and GP stage I/II, additionally divided into USIGP(A) (n = 78) with USI and GP stage I and USIGP(B) (n = 58) with USI and GP stage II, were evaluated with pelvic organ prolapse quantification (POPQ), MT, and CRM. Results. (a) 7.58% had (+) MT with CRM in USIg; (b) in up to 96.15% MT became negative during CRM in USIGP(A); (c) in 51.72% MT became positive only during CRM, as a sign for occult USI in USIGP(B); (d) point Aa (POPQ), which is bladder neck(BN) projection on the anterior vaginal wall, was situated higher in rest position (RP), but moved lower during the Valsalva maneuver (VM) in USIg versus USIGPg (P < 0.05). Conclusion. CRM could be useful arm in selection of (1) patients with isolated USI and great chance for postoperative failure; (2) patients with USI+GP stage I, who need GP repair during antistress surgery; (3) patients with USI + GP stage II, who need antistress procedure during vaginal hysterectomy.Entities:
Year: 2012 PMID: 22523712 PMCID: PMC3302208 DOI: 10.5402/2012/109858
Source DB: PubMed Journal: ISRN Urol ISSN: 2090-5807
Demographic data: age, duration of the postmenopausal age, parity, body mass index (BMI), and ocupation in USIGPg (n = 136) and USIg (n = 132).
| Variable | USIGPg ( | USIg ( |
|
|---|---|---|---|
| Age (years) (mean ± SD) 1 | 61.3 ± 4.5 | 52.2 ± 5.2 | 1.32 |
| Duration of postmenopausal period (years) (mean ± SD) 1 | 13.4 ± 3.3 | 3.7 ± 3.1 |
|
| Parity (mean ± SD)1 | 3.2 ± 0.9 | 2.1 ± 0.6 | 0.60 |
| Body mass index (mean ± SD)1 | 28.3 ± 4.1 | 34.3 ± 4.2 | 1.02 |
| Factory worker 2 | 17/136 | 29/136 | 6.33(†) |
| Farmer 2 | 42/136 | 25/132 | 4.49(†) |
| Clerk/teacher 2 | 8/136 | 28/132 | 14.93(‡) |
| Housewife 2 | 25/136 | 35/132 | 3.05 |
| Retired person 2 | 44/136 | 15/132 | 16.03(‡) |
(1) Student's paired test: (†) P < 0.05; (∗) P < 0.01; (‡) P < 0.001. (2) Mantel-Haenzel's χ 2 test with df of 1: (†) P < 0.05; (∗) P < 0.01; (‡) P < 0.001.
Quantitative description of pelvic organ position (POPQ) with anatomic landmarks in USIGPg (n = 136) and USIg (n = 132).
| POPQ | Rest position | Valsalvas maneuver |
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
| USIGPg ( | USIg ( | USIGPg ( | USIg ( | |||||
| (1) | (2) | (3) | (4) | 1-2 | 3-4 | 1–3 | 2–4 | |
| Aa (cm) | −1.23 ± 0.66 | −1.56 ± 0.78 | −2.39 ± 0.68 | −0.80 ± 0.44 | 0.32 |
| 1.23 | 0.85 |
| Ba (cm) | −0.99 ± 0.88 | −1.43 ± 0.57 | +0.89 ± 0.84 | −0.33 ± 0.24 | 0.50 | 1.39 | 0.55 | 1.79 |
| C (cm) | −1.56 ± 1.11 | −7.24 ± 0.25 | +0.55 ± 1.23 | −5.12 ± 0.88 |
|
| 1.27 |
|
| D (cm) | −4.83 ± 1.36 | −7.55 ± 0.77 | −4.19 ± 1.22 | −5.86 ± 0.99 | 1.74 | 1.06 | 0.35 | 1.35 |
| Bp (cm) | −2.22 ± 0.45 | −2.75 ± 0.55 | −1.10 ± 0.97 | −2.48 ± 0.66 | 0.75 | 1.18 | 1.05 | 0.31 |
| Ap (cm) | −2.00 ± 0.99 | −2.75 ± 0.55 | −1.10 ± 0.97 | −2.48 ± 0.66 | 0.66 | 0.18 | 0.65 | 0.31 |
| gh (cm) | 4.67 ± 0.95 | 3.74 ± 0.99 | 5.11 ± 0.69 | 4.11 ± 0.89 | 0.68 | 0.89 | 0.38 | 0.28 |
| tvl (cm) | 4.51 ± 1.12 | 7.33 ± 0.55 | 3.84 ± 0.87 | 5.58 ± 0.68 |
| 1.58 | 0.47 | 1.76 |
| pb (cm) | 2.18 ± 0.46 | 2.67 ± 0.52 | 2.16 ± 0.77 | 2.45 ± 0.78 | 0.71 | 0.27 | 0.02 | 0.23 |
Student's paired test: (†) P < 0.05; (∗) P < 0.01; (‡) P < 0.001.t 1: differences between column 1 and 2; t 2: differences between column 3 and 4; t 3: differences between column 1 and 3; t 4: differences between column 2 and 4. POPQ: International Continence Society's Pelvic Organ Prolapse Quantification system. Aa: a point located in the midline of the anterior vaginal wall 3 cm proximal to the external urethral meatus; Ba: the most distal position of any part of the upper anterior wall from the vaginal cuff to point Aa; C: leading edge of the cervix; D: the depth of the Douglas recession (distance between the hymen and the most distal point of the Douglas); Bp: the most distal position of any part of the upper posterior wall from the vaginal cuff to point Ap; Ap: a point located in the midline of the posterior vaginal wall 3 cm proximal to the hymen; gh: genital hiatus, measured from the middle of the external urethral meatus to the posterior midline hymen; pb: perineal body, measured from the posterior margin of the genital hiatus to the midanal opening; tvl (total vaginal length): the greatest depth of the vagina in centimeters, that is, the distance between hymen and point D.
Results of the Marshall coughing test during lithotomic position, lithotomic position with cervix reposition, and upright position in USIg (n = 132) and USIGPg(n = 136): USIGP(A) with stage I GP (n = 78) and USIGP(B) with stage II GP (n = 58).
| Study groups | Marshall test in lithotomic position | Marshall test with CRM | Marshall test in upright position | Total (%) |
|---|---|---|---|---|
| USIg ( | (+) | (−) | (−) | 0.0% |
| (+) | (+) | (−) | 0.0% | |
| (+) | (+) | (+) | 10/132 (7.58%) | |
| (−) | (+) | (+) | 0.0% | |
| (−) | (−) | (+) | 20/132 (15.15%) | |
| (+) | (-) | (+) | 102/132 (77.27%) | |
|
| ||||
| USIGP (A) with GP stage I ( | (+) | (−) | (−) | 0.0% |
| (+) | (+) | (−) | 0.0% | |
| (+) | (+) | (+) | 3/78 (3.85%) | |
| (−) | (+) | (+) | 0.0% | |
| (−) | (−) | (+) | 5/78 (6.41%) | |
| (+) | (−) | (+) | 70/78 (89.74%) %) | |
|
| ||||
| USIGP (B) with GP stage II ( | (+) | (−) | (−) | 8/58 (13.79%) |
| (+) | (+) | (−) | 0.0% | |
| (+) | (+) | (+) | 0.0% | |
| (−) | (+) | (+) | 0.0% | |
| (−) | (−) | (+) | 20/58 (34.48%) | |
| (−) | (+) | (−) | 30/58 (51.72%) | |
Differences among the groups regarding the presence of USI during MT in all three positions.
| (+) MT | USIg | USIGP(A) | USIGP(B) |
| ||
|---|---|---|---|---|---|---|
| GP stage 0 ( | GP stage I( | GP stage II ( | ||||
| (1) | (2) | (3) | 1-2 | 1–3 | 2-3 | |
| USI in lithotomic position | 112/132 84.85% | 73/78 93.60% | 28/58 48.28% | 0.69 |
|
|
| USI with CRM | 10/132 | 3/78 | 30/58 | 0.64 |
|
|
| 7.57% | 3.85% | 51.72% | ||||
| USI in upright | 132/132 | 78/78 | 20/68 | 0.00 |
|
|
| 100.00% | 100.00% | 34.48% | ||||
Mantel-Haenszel's χ 2test with df of 1: (‡) P < 0.001. POPQ: International Continence Society's Pelvic Organ Prolapse Quantification system. Stage 0: point Aa, Ba, Bp, and Ap at the level (−3), point C at the level (tvl-2); stage I: the most distal portion of the prolapse is >1 cm above the hymen; stage II: the most distal portion of the prolapse is less or equal to 1 cm proximal to or distal to the plane of the hymen.
Differences among the groups regarding the division of patients and different combinations of the Marshall coughing test during the three positions.
| Marshall test | USI | USIGP(A) | USIGP(B) |
| ||
|---|---|---|---|---|---|---|
| (GP stage 0) ( | (GP stage I) ( | (GP stage II) ( | ||||
| (1) | (2) | (3) | 1-2 | 1–3 | 2-3 | |
| (+) in all three positions | 10/132 | 3/78 | 0/58 | 0.62 |
| 0.85 |
| 13.2% | 5.17% | 0.0% | ||||
| (+) only in up right position | 20/132 | 5/78 | 0/58 | 1.48 |
| 2.26 |
| 15.15% | 6.41% | 0.0% | ||||
| (+) only in lithotomic position | 0/132 | 0/78 | 8/58 | 0.00 |
|
|
| 0.0% | 0.0% | 13.79% | ||||
| (−) only with CRM | 102/132 | 70/78 | 20/58 |
|
|
|
| 77.27% | 89.74% | 34.48% | ||||
| (+) only with CRM | 0/132 | 0/78 | 30/58 | 0.00 |
|
|
| 0.0% | 0.0% | 51.72% | ||||
Mantel-Haenzel's χ 2 test with df of 1: (†) P < 0.05; (∗) P < 0.01; (‡) P < 0.001.
Functional symptoms according to the questionnaire and clinical examination in USIGPg (n = 136) with GP and USI, and USIg (n = 132) with USI.
| USIGPg ( | USIg ( |
| |
|---|---|---|---|
| (1) | (2) | ||
|
| |||
| Potential USI (during prolapse reposition) | 33/136 (24.3%) | 10/132 (7.57%) |
|
| Genuine USI (without prolapse reposition) | 106/136 (77.8%) | 132/132 (100.0%) |
|
| Frequency | 30/136 (22.1%) | 20/132 (15.1%) | 1.67 NS |
| Urgency | 24/136 (19.6%) | 29/132 (22.0%) | 2.26 NS |
| Hesitancy | 30/136 (22.1%) | 25/132 (18.9%) | 0.23 NS |
| Nocturia | 19/136 (14.0%) | 17/132 (12.9%) | 0.03 NS |
| Incomplete emptying | 49/136 (36.1%) | 4/132 (3.0%) |
|
| Weak stream | 42/136 (30.9%) | 4/132 (3.0%) |
|
|
| |||
| Flatus incontinence | 15/136 (11.0%) | 0/132 (0.0%) |
|
| Incontinence of liquid stool | 4/136 (2.9%) | 0/132 (0.0%) | 2.19 NS |
| Urgency of defecation | 19/136 (14.0%) | 0/132 (0.0%) |
|
| Discomfort with defecation | 42/136 (30.9%) | 4/132 (3.0%) |
|
| Constipation | 75/136 (55.1%) | 25/132 (18.9%) |
|
| Digital manipulation to finish defecation | 19/136 (14.0%) | 0/132 (0.0%) |
|
| Feeling of incomplete evacuation | 23/136 (16.9%) | 4/132 (3.0%) |
|
| Rectal protrusion during defecation | 11/136 (8.9%) | 0/132 (0.0%) |
|
|
| |||
| Pain with coitus | 109/136 (80.1%) | 21/132 (15.9%) |
|
| Unsatisfactory coitus | 113/136 (83.1%) | 12/132 (9.1%) |
|
| Decrease in orgasmic response | 117/136 (86.0%) | 49/132 (37.1%) |
|
| Incontinence during the intercourse | 19/136 (14.0%) | 45/132 (34.1%) |
|
|
| |||
| Vaginal pressure and heaviness | 109/136 (80.1%) | 0/132 (0.0%) |
|
| Vaginal/perineal pain | 34/136 (25.0%) | 4/132 (3.0%) |
|
| Low back pain | 113/136 (83.1%) | 4/132 (3.0%) |
|
| Abdominal | 106/136 (77.9%) | 8/132 (6.1%) |
|
Mantel-Haenszel's χ 2 test with df of 1: (†) P < 0.05; (∗) P < 0.01; (‡) P < 0.001.
Urodynamic analyses in USIGPg group (n = 136) with GP and USI, and USIg (n = 132) with USI.
| Urodynamic parameters | USIGPg ( | USIg ( |
|
|---|---|---|---|
| (1) | (2) | 1-2 | |
|
| |||
| Detrusor instability | 38/136 (27.9%) | 33/132 (25.0%) | 0.16 |
| Decreased capacity of the bladder | 57/136 (41.9%) | 37/132 (28.0%) | 5.06 |
| Regular cystometry | 98/136 (72.0%) | 99/132 (75.0%) | 0.47 |
|
| 88.93±11,67 | 90.49 ± 14.22 | 0.25 |
|
| |||
| Positive dUPP (USI (+) according to the urodynamic examination) | 106/136 (77.9%) | 124/132 (93.9%) |
|
| Negative dUPP (USI (−) according to the urodynamic examination) | 30/136 (21.1%) | 8/132 (6.10%) |
|
Mantel-Haenszel's χ 2 test with df of 1: (†) P < 0.05; (∗) P < 0.01; (‡) P < 0.001.